Evidence map›Paper›PMID 24479128›Full record

ArticleThe Analyst2014

Probing hypoxia-induced staurosporine resistance in prostate cancer cells with a microfluidic culture system.

Grishma Khanal, Scott Hiemstra, Dimitri Pappas

Abstract read
In one paragraph

Article in The Analyst, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Grishma KhanalDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA. d.pappas@ttu.edu.
Scott Hiemstra
Dimitri Pappas
Texas Tech University · US

Funding

Rapid Single Molecule Detection System for Intracellular Protease ActivityR21RR025782 · NCRR · TEXAS TECH UNIVERSITY · PI PAPPAS, DIMITRI · 2010 to 2011
$346k
Rapid Single Molecule Detection System for Intracellular Protease ActivityR21GM103550 · NIGMS · TEXAS TECH UNIVERSITY · PI PAPPAS, DIMITRI · 2012 to 2012
$172k
NCRR NIH HHS R21 RR025782NCRR NIH HHS RR025782NIGMS NIH HHS GM103550NIGMS NIH HHS R21 GM103550
6 · The paper itself

Abstract

A microfluidic system for cell culture and drug response studies was developed to elucidate the effects of hypoxia on drug susceptibility. Drug response studies were performed in prostate cancer cells and Ramos B cells under normoxic and hypoxic conditions. A vacuum actuated microfluidic culture device was used for cell culture and PC3 cells were cultured in the chip up to 16 hours. Cells were treated with several concentrations of staurosporine and apoptosis was assayed using the fluorescent probes MitoTracker Deep Red and Annexin-V. For hypoxic samples, the chip was placed in a hypoxia chamber and pre-conditioned at <1% oxygen before inducing the cells with staurosporine. Cells exposed to 2 μM staurosporine were 32% ± 10% apoptotic under normoxic conditions but only 1.5% ± 12% apoptotic under hypoxic conditions. As little as 1 hour of hypoxic preconditioning increased drug resistance. Cell apoptosis correlated with drug dose, although in each case hypoxia reduced the apoptotic fraction significantly. Given the rapid nature of cell adaptation to hypoxia, this chip and analysis approach can be used to identify compounds that can induce cell death in hypoxic tumor cells rapidly.

Indexed as

Drug Resistance, NeoplasmAntineoplastic AgentsApoptosisCell Culture TechniquesCell HypoxiaCell Line, TumorDrug Screening Assays, AntitumorEquipment DesignHumansHypoxiaMaleMicrofluidic Analytical TechniquesProstateProstatic NeoplasmsStaurosporineAntineoplastic AgentsStaurosporine

Identifiers

PMID24479128
PMCPMC4043951
OpenAlexW1964056706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.